• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recommendations on stroke prevention for patients having a CHADS-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines.

作者信息

Chao Tze-Fan, Chen Shih-Ann, Lip Gregory Y H

机构信息

Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.

Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.

出版信息

Trends Cardiovasc Med. 2019 Oct;29(7):427-428. doi: 10.1016/j.tcm.2019.02.008. Epub 2019 Feb 25.

DOI:10.1016/j.tcm.2019.02.008
PMID:30833072
Abstract
摘要

相似文献

1
Recommendations on stroke prevention for patients having a CHADS-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines.2019年心房颤动指南中针对CHADS-VASc评分为1（男性）或2（女性）的患者的卒中预防建议。
Trends Cardiovasc Med. 2019 Oct;29(7):427-428. doi: 10.1016/j.tcm.2019.02.008. Epub 2019 Feb 25.
2
Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.未接受口服抗凝治疗患者的缺血性脑卒中风险评估：基于德国二级数据的观察性队列研究。
BMC Cardiovasc Disord. 2019 Apr 23;19(1):94. doi: 10.1186/s12872-019-1074-7.
3
Implementation of a Fast Healthcare Interoperability Resources-Based Clinical Decision Support Tool for Calculating CHADS-VASc Scores.基于快速医疗保健互操作性资源的CHADS-VASc评分计算临床决策支持工具的实施
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006286. doi: 10.1161/CIRCOUTCOMES.119.006286. Epub 2020 Feb 6.
4
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.基于社区队列研究的 CHA2DS2-VASc 评分为 0 的心房颤动患者的预后。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.
5
Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.心房颤动抗凝治疗预防卒中：临床医生决策与CHA2DS2-VASc及HAS-BLED评分之间的一致性评估
High Blood Press Cardiovasc Prev. 2018 Mar;25(1):61-64. doi: 10.1007/s40292-017-0237-9. Epub 2017 Oct 26.
6
Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations.女性房颤患者的卒中风险：与现行指南建议的关系。
Trends Cardiovasc Med. 2019 Apr;29(3):150-152. doi: 10.1016/j.tcm.2018.07.003. Epub 2018 Jul 12.
7
Augmented intelligence decision tool for stroke prediction combines factors from CHA DS -VASc and the intermountain risk score for patients with atrial fibrillation.增强型人工智能决策工具用于预测中风，结合了 CHA2DS2-VASc 和房颤患者的山间风险评分的因素。
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1452-1461. doi: 10.1111/jce.13999. Epub 2019 Jun 25.
8
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.非瓣膜性心房颤动且 CHA2DS2-VASc 评分为 1 分的患者的口服抗凝治疗：欧洲心脏病学会心血管药物治疗工作组和欧洲心脏病学会卒中委员会的当前观点。
Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):171-180. doi: 10.1093/ehjcvp/pvz016.
9
Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.CHADS2与CHA2DS2-VASc对心房颤动患者独立于抗凝治疗的中风和血栓栓塞预测的荟萃分析。
Tex Heart Inst J. 2015 Feb 1;42(1):6-15. doi: 10.14503/THIJ-14-4353. eCollection 2015 Feb.
10
Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.出院时房颤患者遵循指南指导的抗栓治疗情况评估。
J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):502-508. doi: 10.1177/1074248418778804. Epub 2018 May 27.

引用本文的文献

1
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.亚太心律学会（APHRS）2017年房颤卒中预防共识指南2021年重点更新。
J Arrhythm. 2021 Nov 13;37(6):1389-1426. doi: 10.1002/joa3.12652. eCollection 2021 Dec.
2
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.2021 年亚太心律学会心房颤动卒中预防聚焦更新共识指南：执行摘要。
Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13.
3
Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
心房颤动的中风与出血风险评估：我们目前的进展如何？
Korean Circ J. 2021 Aug;51(8):668-680. doi: 10.4070/kcj.2021.0170. Epub 2021 Jun 1.
4
Stroke prevention in atrial fibrillation: comparison of recent international guidelines.心房颤动的卒中预防：近期国际指南比较
Eur Heart J Suppl. 2020 Dec 22;22(Suppl O):O53-O60. doi: 10.1093/eurheartj/suaa180. eCollection 2020 Dec.